Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-03 · accession 0000950170-25-032760 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-03-03 | SRPT | Estepan Ian Michael | CFO | F - Tax | $103.77 | -557 | 46.3K | -1% | -$57.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | F | D | 557 | $103.77 | 46,326 | D | — | — | (F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024. |